Skip to content

A Clinical Study on the Effect of Herbal Fumigation and Herbal Suppository in Vulvovaginal Candidiasis

Randomized Comparative Clinical Trial To Evaluate the Efficacy of Aragwadhadi Ghanavati aong with Brihatyadi Yoga as Yoni Dhoopana versus Vaginal Suppository in Kaphaja Yonivyapad with special reference to Vulvovaginal Candidiasis. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104491
Enrollment
60
Registered
2026-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B373- Candidiasis of vulva and vagina

Interventions

None listed

Sponsors

Madan Mohan Malviya Government Ayuevedic College Udaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with signs and symptoms of Kaphaja Yonivyapad and vulvovaginal candidiasis such as - Yoni Kandu (Vulvovaginal Itching) and Yoni Srava (Abnormal vaginal discharge) - with or without Yoni shopha (Vulvovaginal odema), Yoni vedana (Vulvovaginal pain / Dyspareunia), Yoni raga (Vulvovaginal redness) or Yoni daha (Vulvovaginal burning sensation). Symptomatic patients confirmed for Vulvovaginal candidiasis by positive KOH wet mount. Documented Pap test as either NILM - Negative for intraepithelial lesion or malignancy or ASCUS - Atypical squamous cells of undetermined significance

Exclusion criteria

Exclusion criteria: Pregnant women . Poorly controlled Diabetes mellitus. Use of systemic or topical anti-fungal medicines within 7 days. Known cases of Sexually transmitted diseases such as HIV infection, HbsAg and Syphilis. Patients with history of or active malignancies. Patient with severe systemic (liver failure, kidney failure, & cardiac diseases) and mental illness.

Design outcomes

Primary

MeasureTime frame
Changes in the signs and symptoms of Kaphaja Yonivyapad with special reference to Vulvovaginal Candidiasis.Timepoint: 8 weeks

Secondary

MeasureTime frame
Mycological eradication assessed with KOH test.Timepoint: 8 weeks

Countries

India

Contacts

Public ContactDr Anu M S

Madan Mohan Malviya Governmrnt Ayurveda College

dranuvaidhya@gmail.com8281801649

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026